Support for persons with autism can cost about a million or more.
Bottom Line: Lifetime support for individuals with autism spectrum disorders (ASDs) ranges from a cost of $1.4 million to $2.4 million in the United States and the United Kingdom.
Autism
Autism is a neurodevelopmental disorder typically characterized by impaired social and communication skills combined with repetitive movements.
Advertisement
Author: Ariane V.S. Buescher, M.Sc., of the London School of Economics and Political Science, and colleagues.
Background: ASD is a neurodevelopmental disorder marked by impaired social ability, especially communication, and repetitive patterns of behavior, interests or activities. The disorders can be associated with significant functional impairment and result in high financial costs for families. The economic effect of ASDs on individuals with the disorder, their families, and society as a whole is poorly understood and has not been updated in light of recent findings.
![Expert Tips to Parents for Children With Autism - Q&A With Child Specialist]( "Expert Tips to Parents for Children With Autism - Q&A With Child Specialist")
On the eve of World Autism Day Dr. Anjana Thadhani, Consulting Developmental Pediatrician says parents and home based program are the backbone of effective treatment plan for children with autism.
How the Study Was Conducted: The authors conducted a literature review of U.S. and U.K. studies on patients with ASD and their families in 2013 to examine costs and economic impact.
Results: The lifetime cost of supporting a patient with ASD and intellectual disability was $2.4 million in the U.S. and the equivalent of $2.2 million in the U.K. The lifetime cost to support a patient with an ASD but without an intellectual disability was $1.4 million in the United States and the equivalent amount in the U.K. The largest segments of cost for children were special education services and the loss of parental productivity. During adulthood, the highest costs were related to residential care or supportive living and individual productivity loss.
Conclusion: "This study presents the most comprehensive estimates to date of the financial costs of ASDs in the United States and the United Kingdom. These costs are much higher than previously suggested. ... There is also an urgent need for a better understanding of the effectiveness and cost-effectiveness of interventions and support arrangements that address the needs and respond to the preferences of individuals with ASDs and their families. Because the economic effects of ASDs in individuals with or without intellectual disability are considerable throughout life, so too should the search for more efficient and equitable use of resources span all age groups." (JAMA Pediatr. Published online June 9, 2014. doi:10.1001/jamapediatrics.2014.210. Available pre-embargo to the media at media.jamanetwork.com.)
Editor's Note: This study was supported by Autism Speaks. Estimates for the United Kingdom were built on previous research funded by the Steve Shirley Foundation. Please see article for additional information, including other authors, author contributions and affiliations, etc.
Editorial: Moving Toward Innovation, Investment Mindset
In a related editorial, Paul T. Shattuck, Ph.D., and Anne M. Roux, M.P.H., of Drexel University, Philadelphia write: "A defining feature of the lives of many people on the autism spectrum is a lifetime of engagement with service systems providing health and therapeutic interventions, education and training, and other societal supports."
"Therefore, getting an autism spectrum disorder diagnosis is not just a medical experience or a service encounter. For the person with autism, diagnosis is a doorway into a social role as a potential lifelong service user. For families, an autism diagnosis can also mean a lifetime of absorbing many of the financial and care-giving burdens associated with the disorder, especially in adulthood when the availability of societal support diminishes."
"Improving our understanding of how life unfolds will require a serious commitment to longitudinal, population-based data collection. For nearly seven decades, evidence from the Framingham Heart Study and other longitudinal studies has laid the foundation for our contemporary understanding of the epidemiology and treatment of cardiovascular disease. We need a Framingham Study for autism spectrum disorders, especially to track risks and outcomes into middle and later adulthood," they conclude. (JAMA Pediatr. Published online June 9, 2014. doi:10.1001/jamapediatrics.2014.585. Available pre-embargo to the media at media.jamanetwork.com.)
Editor's Note: Please see article for additional information, including other authors, author contributions and affiliations, etc.
Source: Eurekalert
Expert Tips to Parents for Children With Autism - Q&A With Child Specialist
On the eve of World Autism Day Dr. Anjana Thadhani, Consulting Developmental Pediatrician says parents and home based program are the backbone of effective treatment plan for children with autism.
Advertisement
How the Study Was Conducted: The authors conducted a literature review of U.S. and U.K. studies on patients with ASD and their families in 2013 to examine costs and economic impact.
Results: The lifetime cost of supporting a patient with ASD and intellectual disability was $2.4 million in the U.S. and the equivalent of $2.2 million in the U.K. The lifetime cost to support a patient with an ASD but without an intellectual disability was $1.4 million in the United States and the equivalent amount in the U.K. The largest segments of cost for children were special education services and the loss of parental productivity. During adulthood, the highest costs were related to residential care or supportive living and individual productivity loss.
Conclusion: "This study presents the most comprehensive estimates to date of the financial costs of ASDs in the United States and the United Kingdom. These costs are much higher than previously suggested. ... There is also an urgent need for a better understanding of the effectiveness and cost-effectiveness of interventions and support arrangements that address the needs and respond to the preferences of individuals with ASDs and their families. Because the economic effects of ASDs in individuals with or without intellectual disability are considerable throughout life, so too should the search for more efficient and equitable use of resources span all age groups." (JAMA Pediatr. Published online June 9, 2014. doi:10.1001/jamapediatrics.2014.210. Available pre-embargo to the media at media.jamanetwork.com.)
Editor's Note: This study was supported by Autism Speaks. Estimates for the United Kingdom were built on previous research funded by the Steve Shirley Foundation. Please see article for additional information, including other authors, author contributions and affiliations, etc.
Editorial: Moving Toward Innovation, Investment Mindset
In a related editorial, Paul T. Shattuck, Ph.D., and Anne M. Roux, M.P.H., of Drexel University, Philadelphia write: "A defining feature of the lives of many people on the autism spectrum is a lifetime of engagement with service systems providing health and therapeutic interventions, education and training, and other societal supports."
"Therefore, getting an autism spectrum disorder diagnosis is not just a medical experience or a service encounter. For the person with autism, diagnosis is a doorway into a social role as a potential lifelong service user. For families, an autism diagnosis can also mean a lifetime of absorbing many of the financial and care-giving burdens associated with the disorder, especially in adulthood when the availability of societal support diminishes."
"Improving our understanding of how life unfolds will require a serious commitment to longitudinal, population-based data collection. For nearly seven decades, evidence from the Framingham Heart Study and other longitudinal studies has laid the foundation for our contemporary understanding of the epidemiology and treatment of cardiovascular disease. We need a Framingham Study for autism spectrum disorders, especially to track risks and outcomes into middle and later adulthood," they conclude. (JAMA Pediatr. Published online June 9, 2014. doi:10.1001/jamapediatrics.2014.585. Available pre-embargo to the media at media.jamanetwork.com.)
Editor's Note: Please see article for additional information, including other authors, author contributions and affiliations, etc.
Source: Eurekalert
Autism - What’s Missing in the Genes?
Scientists have carried out a study on variations in gene expression to evaluate the role of genes in individuals with autism.
Advertisement
 Gene Networks Discovered in Autism may Present Treatment TargetsA new analysis of DNA from thousands of patients has uncovered many underlying gene networks with potentially important roles in autism. | Advertisement
|
Advertisement
Recommended Reading
Latest Child Health News
In 2022, the number of North Korean kids falling under the obese category stood at 47,500 compared with 25,100 in 2012.
In mice the maternal milk provides a key signal that instructs cardiomyocytes to activate lipid metabolism.
Among infants infections from enterovirus are common, but the association to heart muscle inflammation (myocarditis) with severe outcomes is unusual.
New approach called “Eat, Sleep, Console” gets newborns with symptoms of opioid withdrawal out of the hospital sooner and with less medication.
Ground-breaking study has linked poor air quality in India to cognitive deficits in infants, highlighting the potential long-term impact of pollution on child development.